Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome.

Tauber JM, Vanlandingham PA, Zhang B.

PLoS One. 2011;6(11):e27100. doi: 10.1371/journal.pone.0027100.

2.

Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.

Santos AR, Kanellopoulos AK, Bagni C.

Learn Mem. 2014 Sep 16;21(10):543-55. doi: 10.1101/lm.035956.114. Review.

3.

RNA interference: a new mechanism by which FMRP acts in the normal brain? What can Drosophila teach us?

Siomi H, Ishizuka A, Siomi MC.

Ment Retard Dev Disabil Res Rev. 2004;10(1):68-74. Review.

PMID:
14994291
4.

Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention.

Bhogal B, Jongens TA.

Dis Model Mech. 2010 Nov-Dec;3(11-12):693-700. doi: 10.1242/dmm.002006. Review.

5.

Come FLY with us: toward understanding fragile X syndrome.

Zarnescu DC, Shan G, Warren ST, Jin P.

Genes Brain Behav. 2005 Aug;4(6):385-92. Review.

6.

Behavior in a Drosophila model of fragile X.

McBride SM, Bell AJ, Jongens TA.

Results Probl Cell Differ. 2012;54:83-117. doi: 10.1007/978-3-642-21649-7_6. Review.

PMID:
22009349
7.

Understanding fragile X syndrome: insights from animal models.

Bakker CE, Oostra BA.

Cytogenet Genome Res. 2003;100(1-4):111-23. Review.

PMID:
14526171
8.
9.

Deciphering discord: How Drosophila research has enhanced our understanding of the importance of FMRP in different spatial and temporal contexts.

Weisz ED, Monyak RE, Jongens TA.

Exp Neurol. 2015 Dec;274(Pt A):14-24. doi: 10.1016/j.expneurol.2015.05.015. Review.

PMID:
26026973
10.

BDNF in fragile X syndrome.

Castrén ML, Castrén E.

Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Review.

PMID:
23727436
11.

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Ronesi JA, Huber KM.

Sci Signal. 2008 Feb 5;1(5):pe6. doi: 10.1126/stke.15pe6. Review.

PMID:
18272470
12.

The pathophysiology of fragile X (and what it teaches us about synapses).

Bhakar AL, Dölen G, Bear MF.

Annu Rev Neurosci. 2012;35:417-43. doi: 10.1146/annurev-neuro-060909-153138. Review.

13.

Fragile X syndrome: From protein function to therapy.

Bagni C, Oostra BA.

Am J Med Genet A. 2013 Nov;161A(11):2809-21. doi: 10.1002/ajmg.a.36241. Review.

PMID:
24115651
14.

Dysregulation and restoration of translational homeostasis in fragile X syndrome.

Richter JD, Bassell GJ, Klann E.

Nat Rev Neurosci. 2015 Oct;16(10):595-605. doi: 10.1038/nrn4001. Review.

15.

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Santoro MR, Bray SM, Warren ST.

Annu Rev Pathol. 2012;7:219-45. doi: 10.1146/annurev-pathol-011811-132457. Review.

PMID:
22017584
16.

Increasing our understanding of human cognition through the study of Fragile X Syndrome.

Cook D, Nuro E, Murai KK.

Dev Neurobiol. 2014 Feb;74(2):147-77. doi: 10.1002/dneu.22096. Review.

17.

Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Gross C, Berry-Kravis EM, Bassell GJ.

Neuropsychopharmacology. 2012 Jan;37(1):178-95. doi: 10.1038/npp.2011.137. Review.

18.

Understanding fragile X syndrome: insights from retarded flies.

Gao FB.

Neuron. 2002 Jun 13;34(6):859-62. Review.

19.

Fragile X syndrome: from gene discovery to therapy.

Heulens I, Kooy F.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1211-32. Review.

PMID:
21196228
20.

What can we learn about autism from studying fragile X syndrome?

Budimirovic DB, Kaufmann WE.

Dev Neurosci. 2011;33(5):379-94. doi: 10.1159/000330213. Review.

Items per page

Supplemental Content

Support Center